3 Idiopathic Thrombocytopenic Purpura Clinical Trials in Greenville, NC (2026)

Q: How do I join a clinical trial in Greenville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you.

Recruiting Idiopathic Thrombocytopenic Purpura Studies in Greenville

NCT05070845Recruiting

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

This is a Phase 2, open-label, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06835375 in adult participants with primary immune thrombocytopenia (ITP). This study will ...

Greenville, NCPHASE291 participantsPfizer

View Study Details

NCT07059000Recruiting

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP...

Greenville, NCPHASE340 participantsKedrion S.p.A.

View Study Details

NCT07095127Recruiting

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

The purpose of the study is to evaluate the safety of NVG-2089 and to evaluate how well patients respond to this investigational treatment. NVG-2089 is a new drug that is being developed for treating ...

Greenville, NCPHASE230 participantsNuvig Therapeutics, Inc.

View Study Details

About Idiopathic Thrombocytopenic Purpura Clinical Trials in Greenville

Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.

There are currently 3 idiopathic thrombocytopenic purpura clinical trials recruiting participants in Greenville, NC. These studies are seeking a combined 161 participants. Research is being sponsored by Pfizer, Kedrion S.p.A., Nuvig Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Idiopathic Thrombocytopenic Purpura Clinical Trials in Greenville — FAQ

Are there idiopathic thrombocytopenic purpura clinical trials in Greenville?

Yes, there are 3 idiopathic thrombocytopenic purpura clinical trials currently recruiting in Greenville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.

Are clinical trials in Greenville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.

What idiopathic thrombocytopenic purpura treatments are being tested?

The 3 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.

Data updated October 15, 2026 from ClinicalTrials.gov